Yervoy, Bristol-Myers Squibb
Study Supports Nivo-Ipi Combo Over Monotherapy for mRCC
The combination of nivolumab and ipilimumab may be more effective for treating metastatic renal cell carcinoma ...
AUGUST 17, 2017
Yervoy Approved for Pts 12 and Older With Unresectable or Metastatic Melanoma
The FDA approved impilimumab for pediatric patients 12 years and older with unresectable or metastatic melanoma.
JULY 25, 2017
Load more